Massimo Franchini
#96,667
Most Influential Person Now
Researcher
Massimo Franchini's AcademicInfluence.com Rankings
Massimo Franchinicomputer-science Degrees
Computer Science
#3351
World Rank
#3516
Historical Rank
Computational Linguistics
#154
World Rank
#158
Historical Rank
Machine Learning
#378
World Rank
#383
Historical Rank
Artificial Intelligence
#571
World Rank
#582
Historical Rank
Download Badge
Computer Science
Massimo Franchini's Degrees
- PhD Computer Science University of Milan
- Masters Computer Science University of Milan
- Bachelors Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Massimo Franchini Influential?
(Suggest an Edit or Addition)Massimo Franchini's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Expert position paper on air pollution and cardiovascular disease. (2015) (597)
- Air pollution and cardiovascular disease. (2012) (377)
- Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. (2006) (330)
- Health Effects of Ambient Air Pollution in Developing Countries (2017) (302)
- Acquired factor VIII inhibitors. (2008) (275)
- Acquired hemophilia A: A concise review (2005) (250)
- Arterial thrombus formation in cardiovascular disease (2011) (232)
- The paradoxical relationship between serum uric acid and cardiovascular disease. (2008) (222)
- NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men (2008) (212)
- Non-O Blood Type Is the Commonest Genetic Risk Factor for VTE: Results from a Meta-Analysis of the Literature (2012) (210)
- Past, present and future of hemophilia: a narrative review (2012) (206)
- Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox". (2010) (203)
- Prothrombin complex concentrates: an update. (2010) (197)
- Effects on health of air pollution: a narrative review (2015) (194)
- Beyond immunohaematology: the role of the ABO blood group in human diseases. (2013) (192)
- Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications (2007) (191)
- Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. (2008) (182)
- Thrombogenicity and cardiovascular effects of ambient air pollution. (2011) (179)
- Mortality and causes of death in Italian persons with haemophilia, 1990–2007 (2010) (158)
- Heparin-induced thrombocytopenia: an update (2005) (154)
- Haemostasis and pregnancy (2006) (143)
- Hemostasis and aging. (2006) (141)
- Mental depression and cardiovascular disease: a multifaceted, bidirectional association. (2009) (138)
- Fibrinogen replacement therapy: a critical review of the literature. (2012) (134)
- ABO blood group, hypercoagulability, and cardiovascular and cancer risk (2012) (133)
- Phlebotomy issues and quality improvement in results of laboratory testing. (2006) (126)
- Imatinib and regression of type 2 diabetes. (2005) (124)
- The Role of Iron in Diabetes and Its Complications (2007) (123)
- The use of desmopressin as a hemostatic agent: A concise review (2007) (122)
- Effects of secondary prophylaxis started in adolescent and adult haemophiliacs (2008) (122)
- Rituximab in the treatment of adult acquired hemophilia A: a systematic review. (2007) (122)
- Hemophilia A in the third millennium. (2013) (121)
- Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis. (2007) (118)
- Pathogenesis of venous thromboembolism: when the cup runneth over. (2008) (117)
- Inherited platelet disorders. (2008) (116)
- Iron and thrombosis (2007) (113)
- ABO blood group and thrombotic vascular disease (2014) (112)
- The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage (2006) (111)
- Acquired factor V inhibitors: a systematic review (2011) (110)
- Co‐morbidities and quality of life in elderly persons with haemophilia (2010) (106)
- Contemporary platelet function testing (2010) (106)
- Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes (2009) (103)
- Aging Hemostasis: Changes to Laboratory Markers of Hemostasis As We Age—A Narrative Review (2014) (102)
- Acquired von Willebrand syndrome: An update (2007) (102)
- Quality and reliability of routine coagulation testing: can we trust that sample? (2006) (102)
- ABO blood group: old dogma, new perspectives (2013) (102)
- Acquired haemophilia A: A 2013 update (2013) (101)
- Mesenchymal stem cells: from biology to clinical use. (2007) (101)
- Impact on human health of climate changes. (2015) (99)
- COVID‐19 vaccine‐associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome (2021) (95)
- Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice. (2011) (94)
- The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders. (2001) (94)
- Classic thrombophilic gene variants (2015) (93)
- The role of ethnicity, age and gender in venous thromboembolism (2010) (92)
- Thrombotic complications of erythropoiesis-stimulating agents. (2010) (90)
- Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future (2010) (90)
- Help me, Doctor! My D-dimer is raised (2008) (89)
- Increased mean platelet volume in patients with acute coronary syndromes. (2009) (89)
- Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies (2012) (89)
- The intriguing relationship between the ABO blood group, cardiovascular disease, and cancer (2015) (87)
- Systematic Review of the Role of FVIII Concentrates in Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A: A 2013 Update (2013) (86)
- The Use of Recombinant Activated FVII in Postpartum Hemorrhage (2010) (85)
- Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation (2006) (84)
- Cumulative inhibitor incidence in previously untreated patients with severe hemophilia A treated with plasma-derived versus recombinant factor VIII concentrates: a critical systematic review. (2012) (84)
- Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial. (2020) (84)
- Evidence-based recommendations on the treatment of von Willebrand disease in Italy. (2009) (83)
- Safety of intravenous tranexamic acid in patients undergoing majororthopaedic surgery: a meta-analysis of randomised controlled trials. (2018) (83)
- Venous and arterial thrombosis: different sides of the same coin? (2008) (82)
- Vitamin K in neonates: facts and myths. (2011) (82)
- ABO Blood Group and Vascular Disease: An Update (2013) (82)
- Acquired Inhibitors of Coagulation Factors: Part I—Acquired Hemophilia A (2012) (82)
- Helicobacter pylori Infection and Immune Thrombocytopenic Purpura: an Update (2004) (81)
- Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers (2005) (80)
- Disseminated intravascular coagulation in hematologic malignancies. (2010) (80)
- Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. (2002) (79)
- Hereditary iron overload: Update on pathophysiology, diagnosis, and treatment (2006) (78)
- Prophylaxis in Children with Hemophilia: Evidence-Based Achievements, Old and New Challenges (2012) (77)
- A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage. (2008) (77)
- Patient blood management during the COVID–19 pandemic: a narrative review (2020) (77)
- Postpartum acquired factor VIII inhibitors (2006) (75)
- Acquired hemophilia A: a review of recent data and new therapeutic options (2017) (75)
- Von Willebrand factor and thrombosis (2006) (75)
- Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients. (2007) (75)
- Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism (2014) (75)
- Particulate air pollution and cardiovascular risk: short-term and long-term effects. (2009) (75)
- Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients’ analysis (2008) (74)
- Thyroid dysfunction and hemostasis: an issue still unresolved. (2009) (74)
- Milestones and perspectives in coagulation and hemostasis. (2009) (74)
- COVID-19-associated coagulopathy (2020) (74)
- von Willebrand factor and cancer: a renewed interest. (2013) (73)
- Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis. (2018) (73)
- Blood doping by cobalt. Should we measure cobalt in athletes? (2006) (73)
- The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorders (2006) (72)
- The management of hemophilia in elderly patients (2007) (70)
- Influence of a light meal on routine haematological tests. (2010) (70)
- Drug-induced anti-factor VIII antibodies: a systematic review. (2007) (70)
- Thrombotic complications in patients with hereditary bleeding disorders (2004) (69)
- Evolutionary aspects of ABO blood group in humans. (2015) (69)
- Prophylaxis in people with haemophilia (2009) (69)
- Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies (2010) (68)
- Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer. (2005) (68)
- Doping in competition or doping in sport? (2008) (68)
- Von Willebrand disease‐associated angiodysplasia: a few answers, still many questions (2013) (67)
- Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls (2004) (67)
- Hemostatic abnormalities in endocrine and metabolic disorders. (2010) (67)
- Relationship between ABO Blood Group and Hemorrhage: A Systematic Literature Review and Meta-Analysis (2013) (66)
- Hyperthyroidism and Venous Thrombosis: A Casual or Causal Association? A Systematic Literature Review (2011) (66)
- Hepcidin and iron metabolism: from laboratory to clinical implications. (2010) (65)
- Bleeding and thrombosis in multiple myeloma and related plasma cell disorders. (2011) (65)
- Laboratory, clinical and therapeutic aspects of acquired hemophilia A. (2008) (64)
- The prognostic value of ABO blood group in cancer patients. (2016) (64)
- Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease. (2003) (64)
- Association between venous and arterial thrombosis: clinical implications. (2012) (63)
- The metabolic syndrome and the risk of arterial and venous thrombosis. (2008) (62)
- Novel evidence for a greater burden of ambient air pollution on cardiovascular disease (2019) (62)
- The evolution of anticoagulant therapy. (2016) (62)
- Gastrointestinal angiodysplasia and bleeding in von Willebrand disease (2014) (61)
- Diagnosis and Management of Ischemic Heart Disease (2013) (61)
- Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres. (2009) (61)
- Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons? (2010) (61)
- Plasma PAI-1 Levels Are Increased in Patients With Nonalcoholic Steatohepatitis (2007) (60)
- Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. (2014) (60)
- The role of anti-core antibody response in the detection of occult hepatitis B virus infection (2010) (60)
- How I treat rare venous thromboses. (2008) (59)
- Pathogenesis, clinical and laboratory aspects of thrombosis in cancer (2007) (59)
- The modern treatment of haemophilia: a narrative review. (2013) (59)
- Hemostasis, cancer, and ABO blood group: the most recent evidence of association (2013) (58)
- FEIBA versus NovoSeven in Hemophilia Patients with Inhibitors (2013) (58)
- Old and new anticoagulant drugs: A minireview (2011) (58)
- Factor V Leiden and hemophilia. (2010) (58)
- Helicobacter pylori-associated immune thrombocytopenia (2006) (58)
- Red blood cell transfusion policy: a critical literature review. (2017) (57)
- Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management. (2015) (57)
- The effect of iron depletion on chronic hepatitis C virus infection (2008) (57)
- Genetic Risk for Recurrent Urinary Tract Infections in Humans: A Systematic Review (2010) (57)
- Thrombin and Cancer: From Molecular Basis to Therapeutic Implications (2012) (57)
- A new era for anticoagulants. (2009) (57)
- Biochemistry, Physiology, and Complications of Blood Doping: Facts and Speculation (2006) (56)
- Shortened activated partial thromboplastin time: causes and management (2010) (56)
- Air pollution, vascular disease and thrombosis: linking clinical data and pathogenic mechanisms (2012) (55)
- Recombinant activated factor VII: mechanisms of action and current indications. (2010) (55)
- Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: Correlation with Helicobacter pylori infection and response to eradication treatment (2005) (54)
- Inherited and acquired factor V deficiency (2011) (54)
- Vaccination, squalene and anti-squalene antibodies: facts or fiction? (2010) (54)
- Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX (2017) (53)
- Patient Blood Management: a revolutionary approach to transfusion medicine. (2019) (53)
- C-reactive protein and venous thromboembolism: causal or casual association? (2010) (53)
- Coagulation testing in pediatric patients: the young are not just miniature adults. (2007) (53)
- Inhibitor eradication with rituximab in haemophilia: where do we stand? (2014) (52)
- Acquired Inhibitors of Coagulation Factors: Part II (2012) (52)
- Mild hemophilia A (2010) (51)
- Recent advances in hereditary hemochromatosis (2005) (51)
- Von Willebrand factor-containing factor VIII concentrates and inhibitors in haemophilia A (2010) (50)
- Recombinant factor VIIa (2005) (50)
- Platelet gel in the treatment of cutaneous ulcers: the experience of the Immunohaematology and Transfusion Centre of Parma. (2010) (50)
- Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19 (2021) (50)
- Diagnostic approach to inherited bleeding disorders (2007) (50)
- Acquired factor VIII inhibitors in oncohematology: a systematic review. (2008) (50)
- Is serum Cystatin-C a suitable marker of renal function in children? (2007) (49)
- ABO blood group and von Willebrand factor: biological implications (2014) (49)
- Hemophilia and cancer: a new challenge for hemophilia centers. (2009) (49)
- Thromboembolism in childhood nephrotic syndrome: A rare but serious complication (2007) (49)
- Bleeding Complications in Patients with Hematologic Malignancies (2012) (49)
- How to write a scientific manuscript for publication. (2013) (49)
- Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta‐analysis (2014) (49)
- Hemostatic changes in thyroid diseases (2006) (49)
- The impact of the SARS‐CoV‐2 outbreak on the safety and availability of blood transfusions in Italy (2020) (48)
- The first case of acquired hemophilia A associated with SARS‐CoV‐2 infection (2020) (48)
- Acquired FXIII inhibitors: a systematic review (2013) (48)
- New anticoagulants for treatment of venous thromboembolism. (2012) (48)
- Therapy for Children with Henoch-Schonlein Purpura Nephritis: A Systematic Review (2007) (48)
- Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature (2017) (47)
- Acquired hemophilia in pediatrics: A systematic review (2010) (47)
- Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review (2007) (47)
- Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis (2009) (47)
- Interpatient phenotypic inconsistency in severe congenital hemophilia: a systematic review of the role of inherited thrombophilia. (2009) (46)
- High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: A long-term follow-up study (2005) (45)
- Oral Anticoagulant Drugs and the Risk of Osteoporosis: New Anticoagulants Better than Old? (2015) (45)
- Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases. (2007) (45)
- Glanzmann thrombasthenia: an update. (2010) (45)
- Acquired von Willebrand syndrome: focused for hematologists (2020) (45)
- Epidemiological association between fasting plasma glucose and shortened APTT. (2009) (45)
- Expression of CD27 and CD23 on peripheral blood B lymphocytes in humans of different ages. (2009) (45)
- Efficacy of platelet-rich plasma as conservative treatment in orthopaedics: a systematic review and meta-analysis. (2018) (44)
- Unsuspected triggers of venous thromboembolism--trivial or not so trivial? (2009) (44)
- Recombinant factor VIII concentrates. (2010) (44)
- Arthropathy in Patients with Moderate Hemophilia A: A Systematic Review of the Literature (2013) (43)
- Non-factor replacement therapy for haemophilia: a current update. (2018) (43)
- Surgical prophylaxis in von Willebrand's disease: a difficult balance to manage. (2008) (43)
- Operational protocol for donation of anti‐COVID‐19 convalescent plasma in Italy (2020) (43)
- Preventing postsurgical venous thromboembolism: pharmacological approaches. (2011) (42)
- Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications (2009) (42)
- Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potency. (2007) (42)
- Mitigation of air pollution by greenness: A narrative review. (2018) (42)
- Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura. (2008) (42)
- Efficacy of platelet gel in reconstructive bone surgery. (2005) (41)
- Iron-chelation therapy: an update. (2004) (41)
- Relative Risks of Thrombosis and Bleeding in Different ABO Blood Groups (2015) (41)
- Relationship between ABO blood group and pregnancy complications: a systematic literature analysis. (2016) (40)
- Pharmacogenetics of vitamin K antagonists: useful or hype? (2009) (40)
- Pathophysiology, clinics and diagnostics of non-thrombotic pulmonary embolism (2011) (39)
- Non-O blood group: an important genetic risk factor for venous thromboembolism. (2013) (39)
- Thrombocytopenia and infections (2017) (39)
- The natural history of mild haemophilia: a 30‐year single centre experience (2012) (39)
- Sleep apnea and venous thromboembolism (2015) (39)
- New strategies for doping control (2008) (39)
- Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol (2020) (39)
- Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter interventional trial (2020) (39)
- Plasma-derived versus recombinant Factor VIII concentrates for the treatment of haemophilia A: recombinant is better. (2010) (38)
- Idiopathic thrombocytopenic purpura, Helicobacter pylori infection, and HLA class II alleles. (2002) (38)
- The History of Hemophilia (2014) (38)
- Innovative Pharmacological Therapies for the Hemophilias Not Based on Deficient Factor Replacement (2016) (38)
- Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients (2009) (37)
- The genetic basis of coronary artery disease: from candidate genes to whole genome analysis. (2008) (37)
- The use of desmopressin in acquired haemophilia A: a systematic review. (2011) (37)
- The platelet function analyzer (PFA-100): an update on its clinical use. (2005) (36)
- Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine (2021) (36)
- Association between particulate air pollution and venous thromboembolism: A systematic literature review. (2016) (36)
- Von Willebrand factor: another janus-faced hemostasis protein. (2008) (36)
- Sudden cardiac death: Prevalence, pathogenesis, and prevention (2008) (36)
- The Role Of von Willebrand Factor In Hemorrhagic And Thrombotic Disorders (2007) (36)
- Treatment of hemophilia B: focus on recombinant factor IX (2013) (36)
- The platelet-function analyzer (PFA-100 ® ) for evaluating primary hemostasis (2005) (36)
- The management of cardiovascular diseases in patients with hemophilia. (2010) (36)
- Biological therapies for von Willebrand disease (2012) (36)
- Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis. (2008) (36)
- Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide (2013) (35)
- The bidirectional relationship of cancer and hemostasis and the potential role of anticoagulant therapy in moderating thrombosis and cancer spread. (2009) (35)
- Coagulopathies and thrombosis: usual and unusual causes and associations, part I. (2009) (34)
- COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes (2022) (34)
- Cancer-associated thrombosis: investigating the role of new oral anticoagulants. (2015) (34)
- New antiplatelet agents: why they are needed. (2009) (34)
- Helicobacter Pylori-Associated Idiopathic Thrombocytopenic Purpura: A Narrative Review (2012) (33)
- Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy. (2011) (33)
- A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate®P/ Humate®‐P: History and clinical performance (2008) (33)
- Emicizumab for the treatment of haemophilia A: a narrative review. (2019) (33)
- Helicobacter pylori infection and immune thrombocytopenic purpura. (2003) (33)
- Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. (2006) (32)
- Diagnostics of Inherited Bleeding Disorders of Secondary Hemostasis: An Easy Guide for Routine Clinical Laboratories (2016) (32)
- The use of fibrinogen concentrate for the management of trauma-related bleeding: a systematic review and meta-analysis. (2017) (32)
- Dark chocolate: consumption for pleasure or therapy? (2009) (32)
- [Acquired von Willebrand syndrome]. (2020) (31)
- Hemostatic changes in thyroid diseases: haemostasis and thrombosis. (2006) (31)
- Laboratory assessment and perioperative management of patients on antiplatelet therapy: from the bench to the bedside. (2009) (31)
- The use of recombinant activated factor VII in congenital and acquired von Willebrand disease. (2006) (31)
- Hemostasis and thyroid diseases revisited (2004) (31)
- Thrombocytopenias: a clinical point of view. (2009) (31)
- Thrombotic microangiopathies: An update (2006) (31)
- Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination (2021) (31)
- Preoperative autologous blood donation by 1073 elderly patients undergoing elective surgery: a safe and effective practice (1999) (30)
- Low-molecular-weight heparins and cancer: Focus on antitumoral effect (2015) (30)
- Clinical use of factor VIII and factor IX concentrates. (2013) (30)
- Hemostatic disorders in type 1 diabetes mellitus. (2011) (30)
- Solvent/detergent plasma: pharmaceutical characteristics and clinical experience (2014) (29)
- Issues in pediatric haemophilia care (2013) (29)
- High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery. (2004) (29)
- Fresh frozen homologous bone in oral surgery: case reports (2008) (29)
- Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers (2012) (29)
- Anaphylaxis in patients with congenital bleeding disorders and inhibitors (2009) (29)
- Clinical, laboratory and therapeutic aspects of platelet‐type von Willebrand disease (2008) (29)
- Is solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus document. (2016) (29)
- The spectrum of coagulation abnormalities in thyroid disorders. (2011) (29)
- Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review. (2019) (28)
- Venous thromboembolism in chronic liver disease. (2011) (28)
- Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma. A proof-of-concept, single-arm, multicenter trial (2020) (28)
- Idiopathic thrombocytopenic purpura in pregnancy: analysis of 43 consecutive cases followed at a single Italian institution (2006) (28)
- The use of desmopressin in mild hemophilia A (2010) (28)
- One-stage clotting versus chromogenic assays for assessing recombinant factor VIII: two faces of a haemostasis coin. (2009) (28)
- The use of desmopressin in congenital factor XI deficiency: a systematic review (2009) (28)
- Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease (2016) (28)
- Prophylaxis in von Willebrand disease (2007) (28)
- Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review (2021) (28)
- Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs (2006) (28)
- Atypical hemolytic uremic syndrome: from diagnosis to treatment (2015) (27)
- COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors (2021) (27)
- Uncertain thrombophilia markers (2016) (27)
- The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program. (2016) (27)
- Recombinant Factor VIIa: A Review on its Clinical Use (2006) (27)
- Interactions between genotype and phenotype in bleeding and thrombosis (2008) (27)
- Red wine and cardiovascular health the "French Paradox" revisited (2010) (27)
- Sudden cardiac death in young athletes. (2008) (27)
- ABO blood group and COVID-19: an updated systematic literature review and meta-analysis. (2021) (27)
- Thyroid-associated autoimmune coagulation disorders (2009) (27)
- Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery (2002) (27)
- Haemolysis index for the screening of intravascular haemolysis: a novel diagnostic opportunity? (2018) (27)
- The use of recombinant activated factor VII in platelet disorders: a critical review of the literature. (2009) (27)
- Blood safety and zoonotic emerging pathogens: now it's the turn of Zika virus! (2016) (27)
- COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis (2022) (26)
- Emerging Issues on Comprehensive Hemophilia Care: Preventing, Identifying, and Monitoring Age-Related Comorbidities (2013) (26)
- Thrombotic thrombocytopenic purpura: proposal of a new pathogenic mechanism involving Helicobacter pylori infection. (2005) (26)
- Dangers in the Practice of Defensive Medicine in Hemostasis Testing for Investigation of Bleeding or Thrombosis: Part I—Routine Coagulation Testing (2014) (26)
- Inherited disorders of blood coagulation (2012) (26)
- Direct oral anticoagulants and venous thromboembolism (2016) (26)
- Extracorporeal immunoadsorption for the treatment of coagulation inhibitors. (2009) (25)
- Low-density lipoprotein receptor-related protein 1: new functions for an old molecule (2011) (25)
- Evaluation of cryopreserved donor skin viability: the experience of the regional tissue bank of Verona. (2009) (25)
- Towards the implementation of patient blood management across Europe. (2017) (24)
- Air pollution and coagulation testing: a new source of biological variability? (2008) (24)
- Routine coagulation tests in newborn and young infants (2007) (24)
- Advances in hematology. Etiology and diagnosis of acquired von Willebrand syndrome. (2010) (24)
- Sports anaemia: facts or fiction? (2012) (24)
- Inherited factor XI deficiency: A concise review (2006) (24)
- Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease (2013) (24)
- Present and future challanges in the treatment of haemophilia: a clinician's perspective. (2013) (24)
- A retrospective study assessing the characteristics of COVID‐19 convalescent plasma donors and donations (2020) (24)
- Correlation between ABO Blood Group, and Conventional Hematological and Metabolic Parameters in Blood Donors (2015) (24)
- Evaluating kidney damage from vesico-ureteral reflux in children. (2009) (24)
- Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels (2005) (23)
- The Health and Economic Burden of Air Pollution. (2015) (23)
- Management of Bleeding Associated with New Oral Anticoagulants (2015) (23)
- Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies. (2017) (23)
- The use of recombinant factor VIIa in liver diseases (2008) (22)
- Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature (2015) (22)
- [Helicobacter pylori infection and idiopathic thrombocytopenic purpura]. (2005) (22)
- Comparison of JAK2V617F mutation assessment employing different molecular diagnostic techniques. (2009) (22)
- Hidden high-grade vesicoureteral reflux is the main risk factor for chronic renal damage in children under the age of two years with first urinary tract infection (2009) (22)
- Forum on: the role of recombinant factor VIII in children with severe haemophilia A (2009) (22)
- Haemophilia B: current pharmacotherapy and future directions (2012) (22)
- Fibrotic interstitial lung diseases and air pollution: a systematic literature review (2020) (22)
- Platelets and immunity: the interplay of mean platelet volume in health and disease (2015) (22)
- Remission of severe antiphospholipid syndrome associated with non-Hodgkin's B-cell lymphoma after combined treatment with rituximab and chemotherapy. (2005) (22)
- Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A (2006) (22)
- Inflammation and hemostasis: a bidirectional interaction. (2007) (22)
- Comparison of creatinine-based estimations of glomerular filtration rate in endurance athletes at rest (2008) (21)
- Acquired hemophilia A. (2006) (21)
- The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19 (2021) (21)
- Ten years since the last Chikungunya virus outbreak in Italy: history repeats itself. (2017) (21)
- The never ending success story of tranexamic acid in acquired bleeding (2020) (21)
- The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement. (2007) (21)
- COVID‐19 convalescent plasma therapy: hit fast, hit hard! (2021) (21)
- Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders (2020) (21)
- Inhibitors in mild/moderate haemophilia A: An update (2006) (20)
- Changes of human B and B-1a peripheral blood lymphocytes with age (2007) (20)
- Recent improvements in the clinical treatment of coagulation factor inhibitors. (2009) (20)
- The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review (2007) (20)
- Prophylactic use of desmopressin in surgery of six patients with symptomatic heterozygous factor XI deficiency. (2000) (20)
- Thrombotic risk in children with COVID-19 infection: A systematic review of the literature (2021) (20)
- Update on the Treatment of Disseminated Intravascular Coagulation (2004) (20)
- Screening and therapeutic management of lipoprotein(a) excess: review of the epidemiological evidence, guidelines and recommendations. (2011) (20)
- TCF2 gene mutation leads to nephro-urological defects of unequal severity: an open question. (2008) (20)
- Hepatitis C in haemophiliacs (2004) (20)
- The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review (2020) (20)
- Convalescent plasma for coronavirus disease 2019 in pregnancy: a case report and review (2020) (20)
- Recombinant human erythropoietin facilitates autologous blood collections in children undergoing corrective spinal surgery (2004) (20)
- Adjunct agents for bleeding (2014) (19)
- Evaluation of the PFA-100 system for monitoring desmopressin therapy in patients with type 1 von Willebrand's disease. (2002) (19)
- Immune tolerance induction for patients with severe hemophilia A: a critical literature review (2011) (19)
- Treatment of hepatitis C in hemophiliacs (2006) (19)
- Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations (2021) (19)
- Transfusion thresholds and beyond. (2016) (19)
- Antithrombotic prophylaxis in patients with von Willebrand disease undergoing major surgery: when is it necessary? (2009) (19)
- Plasma Leptin in Patients at Intermediate to High Cardiovascular Risk With and Without Type 2 Diabetes Mellitus (2017) (19)
- Determinants of anaemia in the very elderly: a major contribution from impaired renal function? (2010) (19)
- Inhibitor incidence in previously untreated patients with severe haemophilia B: a systematic literature review (2016) (19)
- Non‐thrombotic‐, non‐inhibitor‐associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand’s disease: a systematic review of prospective studies (2012) (19)
- Tailoring hemostatic therapies to lower inhibitor development in previously untreated patients with severe hemophilia A (2016) (19)
- Influenza and cardiovascular disease: does swine-origin, 2009 H1N1 flu virus represent a risk factor, an acute trigger, or both? (2010) (19)
- Recent acquisitions in acquired and congenital von Willebrand disorders. (2007) (19)
- Safety and Efficacy of Convalescent Plasma in Elderly COVID-19 Patients: The RESCUE Trial (2021) (19)
- Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians (2018) (18)
- Are children with congenital solitary kidney at risk for lifelong complications? A lack of prediction demands caution (2008) (18)
- Deep vein thrombosis after orthopedic surgery in a patient with type 1 von Willebrand disease and mutations in the MTHFR and beta-fibrinogen genes (2003) (18)
- Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources (2022) (18)
- Clinical Judgment When Using Coagulation Tests during Direct Oral Anticoagulant Treatment: A Concise Review (2013) (18)
- Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma (2008) (18)
- The use of fresh-frozen bone in oral surgery: a clinical study of 14 consecutive cases. (2011) (18)
- Inhibitors in mild/moderate haemophilia A: two case reports and a literature review. (2008) (18)
- The post-operative management of anaemia: more efforts are needed. (2018) (18)
- Current management of hemophilia B: recommendations, complications and emerging issues (2014) (18)
- Clinical Efficacy and Determinants of Response to Treatment with Desmopressin in Mild Hemophilia A (2013) (18)
- The use of viscoelastic haemostatic assays in non-cardiac surgical settings: a systematic review and meta-analysis. (2018) (18)
- Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long‐term survivors of acute leukemia (2004) (18)
- Serum eye drops for the treatment of ocular surface diseases: a systematic review and meta-analysis. (2019) (18)
- Modifiers of clinical phenotype in severe congenital hemophilia. (2017) (17)
- Urological complications and copper replacement therapy in childhood Menkes syndrome. (2006) (17)
- Haemophilia B is clinically less severe than haemophilia A: further evidence. (2018) (17)
- Factor V Leiden in women: a thrombotic risk factor or an evolutionary advantage? (2011) (17)
- ABO blood group and risk of coronary artery disease (2013) (17)
- The hemostatic balance revisited through the lessons of mankind evolution (2008) (17)
- Is serum procalcitonin able to predict long-term kidney morbidity from urinary tract infections in children? (2008) (17)
- The protective effect of O blood type against SARS‐CoV‐2 infection (2020) (17)
- Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey (2014) (17)
- Why should we use convalescent plasma for COVID-19? (2020) (16)
- Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients (2016) (16)
- Higher morning serum cortisol level predicts increased fibrinogen but not shortened APTT (2008) (16)
- How we treat bleeding associated with direct oral anticoagulants. (2016) (16)
- Ceftriaxone‐induced hemolysis in an adult (2000) (16)
- Solvent/detergent-treated plasma: a tale of 30 years of experience (2015) (16)
- Serum ferritin levels correlate with haemoglobin concentration: a report on 589 outpatients from a single centre. (2007) (16)
- Utility of testing for factor V Leiden. (2012) (16)
- Atherothrombosis in von Willebrand Disease: An Analysis of the Literature and Implications for Clinical Management (2012) (16)
- Alcohol consumption and venous thromboembolism: friend or foe? (2015) (16)
- Platelet-rich plasma for sports-related muscle, tendon and ligament injuries: an umbrella review. (2019) (16)
- Primary hyperfibrinolysis: Facts and fancies. (2018) (16)
- Alloantibodies in von Willebrand Disease (2017) (16)
- Advantages and limits of ADAMTS13 testing in the prognostic assessment of thrombotic thrombocytopenic purpura. (2012) (15)
- The use of platelet-rich plasma in oral surgery: a systematic review and meta-analysis. (2019) (15)
- Diagnostics in Venous Thromboembolism: From Origin to Future Prospects (2015) (15)
- Lipaemic donations: truth and consequences. (2013) (15)
- Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews (2021) (15)
- Evidence-based treatment limitations prevent any therapeutic recommendation for acute poststreptococcal glomerulonephritis in children. (2010) (15)
- Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature. (2015) (15)
- Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload: an update. (2004) (15)
- Errors in transfusion: causes and measures to avoid them (2010) (15)
- Update on chronic hepatitis C in hemophiliacs. (2002) (15)
- Genomics and proteomics in venous thromboembolism: building a bridge toward a rational personalized medicine framework. (2007) (14)
- Clinical heterogeneity of acquired hemophilia A: a description of 4 cases. (2005) (14)
- The real value of thrombophilia markers in identifying patients at high risk of venous thromboembolism (2014) (14)
- Characterization of a novel mutation in the F8 promoter region associated with mild hemophilia A and resistance to DDAVP therapy (2009) (14)
- Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET (2020) (14)
- Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient (2005) (14)
- Recombinant human erythropoietin might induce strawberry haemangiomas in very‐low‐birthweight preterm infants (2003) (14)
- New Therapeutic Strategies with Combined Renin‐Angiotensin System Inhibitors for Pediatric Nephropathy (2008) (14)
- Prohibition of artificial hypoxic environments in sports: health risks rather than ethics. (2007) (14)
- Ex-vivo red blood cells generation: a step ahead in transfusion medicine? (2011) (14)
- The Three Pillars of COVID-19 Convalescent Plasma Therapy (2021) (14)
- Detection of an early HIV‐1 infection by HIV RNA testing in an Italian blood donor during the preseroconversion window period (2003) (14)
- Idiopathic thrombocytopenia and Helicobacter pylori infection: platelet count increase and early eradication therapy. (2011) (14)
- Prostate-specific antigen, prostate cancer, and disorders of hemostasis. (2009) (14)
- Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done? (2008) (14)
- Blood group distribution and life-expectancy: a single-centre experience. (2015) (13)
- Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1 (2022) (13)
- Inherited thrombophilia. (2006) (13)
- Inherited thrombophilia: an update. (2005) (13)
- Glomerular Filtration Rate in Endurance Athletes (2008) (13)
- Holiday thrombosis. (2011) (13)
- Management of inherited dysfibrinogenemia during pregnancy: a description of four consecutive cases (2007) (13)
- Interferon and ribavirin in HIV‐negative haemophiliacs with chronic hepatitis C who were nonresponders to a previous interferon treatment (2002) (13)
- Prophylaxis for adults with haemophilia: towards a personalised approach? (2012) (13)
- Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis. (2014) (13)
- Alcohol dosing and the heart: updating clinical evidence. (2011) (13)
- Serum Ferritin as a Marker of Potential Biochemical Iron Overload in Athletes (2005) (13)
- ABO blood group and neurodegenerative disorders: more than a casual association. (2016) (13)
- Lipoprotein apheresis for the treatment of elevated circulating levels of lipoprotein(a): a critical literature review. (2016) (13)
- Identification of spurious hemolysis in anticoagulated blood with Sysmex XE-2100 and Siemens Advia 2120. (2012) (13)
- Rituximab for the treatment of childhood chronic idiopathic thrombocytopenic purpura and hemophilia with inhibitors (2007) (12)
- An unusual case of a spurious, transfusion-acquired haemoglobin S. (2010) (12)
- Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT (2012) (12)
- Iron overload and hematologic malignancies. (2004) (12)
- The Use of Plasma‐Derived Concentrates (2011) (12)
- Clinical predictors of SARS‐CoV‐2 neutralizing antibody titers in COVID‐19 convalescents: Implications for convalescent plasma donor recruitment (2021) (12)
- Newer Hemostatic Agents (2015) (12)
- Quality of Transfusion Products in Blood Banking (2014) (12)
- Intermittent hypoxic training: doping or what? (2009) (12)
- Coagulopathies and thrombosis: usual and unusual causes and associations, part III. (2010) (12)
- Rare congenital bleeding disorders. (2018) (12)
- Lipoprotein(a) and ageing. (2010) (12)
- Coagulopathies and thrombosis: usual and unusual causes and associations, Part II. (2009) (12)
- High prevalence of inherited prothrombotic risk factors in 134 consecutive patients with von Willebrand disease (2006) (12)
- Eosinophilia and first-line coagulation testing (2009) (12)
- Hemophilia severity score system: validation from an Italian Regional Hemophilia Reference Center (2009) (12)
- Acquired coagulation inhibitor-associated bleeding disorders: An update (2005) (12)
- Patient preference for needleless factor VIII reconstitution device: the Italian experience (2010) (11)
- Pathophysiology, diagnosis and treatment of disseminated intravascular coagulation: an update. (2005) (11)
- Potential mechanisms of action of convalescent plasma in COVID-19 (2021) (11)
- Iron overload in acute myeloid leukemia patients is not related to HFE and TFR2 gene mutations. (2003) (11)
- Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitis (2013) (11)
- Recurrent venous thromboembolism: a role for ABO blood group? (2013) (11)
- Prophylaxis in congenital hemophilia with inhibitors: the role of recombinant activated factor VII. (2009) (11)
- A cost analysis of public cord blood banks belonging to the Italian Cord Blood Network. (2018) (11)
- Are only haemophiliacs protected against ischemic heart disease? (2004) (11)
- Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia (2017) (11)
- The utility of thrombophilia testing (2014) (11)
- Controversies in Inherited Bleeding Disorders (2016) (11)
- Absence of thromboembolic complications in patients with hereditary bleeding disorders undergoing major orthopaedic surgery without antithrombotic prophylaxis (2004) (11)
- Analysis of HFE and TFR2 gene mutations in patients with acute leukemia. (2005) (11)
- Prevalence of hepatitis C virus infection in IgM‐type monoclonal gammopathy of uncertain significance and Waldenström macroglobulinemia (2004) (11)
- Haematology clinic: Haemophilia A (2014) (11)
- Prevention of inhibitor development in hemophilia A in 2016. A glimpse into the future? (2016) (10)
- Frequency and type of newly diagnosed haemoglobin variants in Northern Italy. (2010) (10)
- Acquired hemophilia A (2006) (10)
- Alloantibodies in previously untreated hemophilia A patients: the role of environmental factors (2013) (10)
- Role of ABO blood group as a prognostic factor in patients with spontaneous intracerebral hemorrhage (2013) (10)
- Advances in the diagnosis and management of von Willebrand disease (2006) (10)
- Adjuvant treatments for Henoch-Schönlein purpura nephritis in children: A systematic review. (2009) (10)
- Genetics of the acute coronary syndrome. (2016) (10)
- NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann’s thrombasthenia (2014) (10)
- Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres (2015) (10)
- Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies (2020) (10)
- The safety of pharmacologic options for the treatment of persons with hemophilia (2016) (10)
- The use of recombinant activated factor VII in platelet-associated bleeding (2008) (10)
- Convalescent Plasma for the Treatment of Severe COVID-19 (2021) (10)
- Preoperative autologous blood donation in primary total knee arthroplasty: critical review of current indications (2008) (10)
- Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy. (2011) (10)
- Target of prophylaxis in severe haemophilia: more than factor levels. (2013) (10)
- COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review (2021) (10)
- Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive? (2004) (9)
- The use of central venous catheters in haemophilia patients (2010) (9)
- Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding. (2022) (9)
- Comparison of platelet function between sedentary individuals and competitive athletes at rest (2006) (9)
- Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency (2021) (9)
- Helicobacter pylori infection and idiopathic thrombocytopenic purpura: description of 21 newly diagnosed cases. (2004) (9)
- Coagulopathies and thrombosis: usual and unusual causes and associations, Part IV. (2011) (9)
- Von Willebrand's Disease. (2017) (9)
- Treatment Regimens with Bypassing Agents in Patients with Hemophilia A and Inhibitors: A Survey from the Italian Association of Hemophilia Centers (AICE) (2018) (9)
- Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19 (2020) (9)
- Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review (2022) (9)
- Pain assessment and management in Italian Haemophilia Centres. (2020) (9)
- How Safe Is COVID-19 Convalescent Plasma? (2021) (9)
- The key role of tranexamic acid in Patient Blood Management programmes. (2018) (9)
- Primary Cutaneous Plasmacytoma after Rejection of a Transplanted Kidney: Case Report and Review of the Literature (2004) (9)
- [Mesenchymal stem cells: from biology to clinical applications]. (2003) (9)
- Mechanism of hemostasis defects and management of bleeding in patients with acute coronary syndromes. (2010) (9)
- Management of coronary artery disease in a severe haemophilia patient with high titre inhibitor and anaphylaxis (2009) (9)
- Are convalescent plasma stocks collected during former COVID‐19 waves still effective against current SARS‐CoV‐2 variants? (2022) (8)
- Antagonists of activated factor X and thrombin: innovative antithrombotic agents. (2007) (8)
- The use of recombinant activated factor VII in life‐threatening postpartum hemorrhage (2007) (8)
- Inherited Thrombophilia (2006) (8)
- Haemophilia and cancer: a personal perspective. (2013) (8)
- Inherited and acquired risk factors for arterial ischemic stroke in childhood (2009) (8)
- Intensive blood transfusion support in acquired hemophilia A (2007) (8)
- Is there a standard-of-care for transfusion therapy in thalassemia? (2017) (8)
- Thirty-minutes’ exposure to smartphone call triggers neutrophil activation in vitro (2016) (8)
- Coagulopathies and thrombosis: usual and unusual causes and associations. Part V. (2011) (8)
- Biochemical correlates of lipoprotein(a) in a general adult population. Possible implications for cardiovascular risk assessment (2007) (8)
- The International Anti-Doping System: why it might not work. (2009) (8)
- Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience (2022) (8)
- Thromboembolic risk in hematological malignancies (2015) (8)
- Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review (2021) (8)
- Hemostatic Agents for Bleeding: Recombinant-Activated Factor VII and Beyond (2014) (8)
- The cost-benefit ratio of screening pregnant women for thrombophilia. (2007) (8)
- Recent acquisitions in the management of iron overload (2005) (8)
- Lipoprotein(a), Thrombophilia and Venous Thrombosis (2007) (7)
- Recombinant factor VIIa as haemostatic therapy in advanced liver disease. (2013) (7)
- Peripheral blood CD5-positive B lymphocytes (B-1a cells) after allogeneic stem cell transplantation for acute myeloid leukaemia in humans. (2008) (7)
- Venous thromboembolism and coffee: critical review and meta-analysis. (2015) (7)
- Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources (2022) (7)
- Helicobacter pylori eradication in adults with idiopathic thrombocytopenic purpura. (2003) (7)
- Pathogenesis, laboratory, and clinical characteristics of Helicobacter pylori-associated immune thrombocytopenic purpura. (2010) (7)
- Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapy (2012) (7)
- The use of whole blood in traumatic bleeding: a systematic review (2020) (7)
- Diagnosis of anemia in pregnancy (2020) (7)
- Genetic determinants of extreme longevity: the role of ABO blood group (2016) (7)
- Hypercoagulability in congenital haemolytic anaemias. (2012) (7)
- COMPARATIVE ANALYSIS OF ANTIBODY RESPONSES FROM COVID-19 CONVALESCENTS RECEIVING VARIOUS VACCINES REVEALS CONSISTENT HIGH NEUTRALIZING ACTIVITY FOR SARS-CoV-2 VARIANT OF CONCERN OMICRON. (2021) (7)
- The Role of ABO Blood Type in Thrombosis Scoring Systems (2017) (7)
- RODIN and the pitfalls of observational studies (2013) (7)
- Investigational drugs to treat hemophilia (2020) (7)
- [Role of biochemical risk factors and markers for the risk of atherosclerosis]. (2008) (7)
- Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer. (2001) (7)
- Non-O blood group as a risk factor for cerebral vein thrombosis (2013) (7)
- Recombinant human erythropoietin in pediatric patients: efficacy in facilitating autologous blood donation in spinal deformity surgery. (2004) (7)
- Normobaric hypoxia and sports: the debate continues (2010) (6)
- Efficacy and safety of a recombinant factor VIII produced from a human cell line (simoctocog alfa) (2017) (6)
- Clinical use and the Italian demand for prothrombin complex concentrates. (2013) (6)
- O blood group is a risk factor for severe mucosal hemorrhage in orally anticoagulated patients (2013) (6)
- The demand for factor VIII and for factor IX and the toll fractionation product surplus management. (2013) (6)
- Acute myeloid leukemia in the elderly: evaluation of overall survival in 69 consecutive patients. (2002) (6)
- Platelets and lipoprotein(a) in retinal vein occlusion: Mutual targets for aspirin therapy (2007) (6)
- Plasma D-dimer in the diagnosis of acute aortic dissection. (2008) (6)
- Influence of warfarin therapy on activated factor VII clotting activity (2006) (6)
- Together we care: new challenges for global haemophilia treatment centers. (2009) (6)
- Impact of Exercise/Sport on Well-being in Congenital Bleeding Disorders (2018) (6)
- Gene therapy for hemophilia A. Friend or foe? (2009) (6)
- Is the activated partial thromboplastin time suitable to screen for von Willebrand factor deficiencies? (2007) (6)
- Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs? (2006) (6)
- How I treat Acquired factor VIII inhibitors (2008) (6)
- Malignant evolution of monoclonal gammopathy of undetermined significance: analysis of 633 consecutive cases with a long term follow-up. (2004) (6)
- Methylation Reactions, the Redox Balance and Atherothrombosis: The Search for a Link with Hydrogen Sulfide (2015) (6)
- Thrombotic complications in von Willebrand disease (2006) (6)
- LRP1/CD91 is up‐regulated in monocytes from patients with haemophilia A: a single‐centre analysis (2013) (5)
- Recombinant activated factor VII in clinical practice: a 2014 update (2015) (5)
- Platelet Count Increase Following Phlebotomy in Iron Overloaded Patients with Liver Cirrhosis (2003) (5)
- Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients (2022) (5)
- Long-term persistence of molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia. (2012) (5)
- Multiple gene interaction and modulation of hemostatic balance (2009) (5)
- Lipoprotein(a), athero-thrombosis and longevity. A historical paradox finally elucidated? (2007) (5)
- Management of Hemophilia in Older Patients (2017) (5)
- Searching for the role of primary prophylaxis in preventing inhibitor development in hemophilia A (2012) (5)
- Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review (2022) (5)
- Prophylactic management of patients with von Willebrand disease (2021) (5)
- Laboratory diagnostics and therapy in thrombosis and hemostasis: from bedside to bench to bedside. (2009) (5)
- Association between haemophilia and inherited thrombophilia: a single centre survey (2011) (5)
- Acquired haemophilia A as a blood transfusion emergency. (2008) (5)
- O blood type is a risk factor for upper gastrointestinal bleeding (2017) (5)
- The importance of ABO blood group in pharmacokinetic studies in haemophilia A (2018) (5)
- Association between SARS-CoV-2 infection or vaccination and acquired hemophilia A: A case report and literature update (2022) (5)
- Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study (2015) (5)
- Relationship between hematocrit, primary hemostasis, and cardiovascular disease in athletes. (2002) (5)
- Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor–recipient differences in concentration of neutralizing antibodies (2021) (5)
- The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complex (2007) (5)
- Clinical use and the Italian demand for antithrombin. (2013) (5)
- Emerging drugs for hemophilia B (2014) (4)
- Convalescent plasma therapy for managing infectious diseases: a narrative review (2021) (4)
- Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates. (2013) (4)
- Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19. (2023) (4)
- Thalidomide for hereditary haemorrhagic telangiectasia. (2015) (4)
- Hereditary hemochromatosis. (2005) (4)
- The use of novel oral anticoagulants: the debate continues! (2015) (4)
- The syndrome of the “obsessive-compulsory scientist”: a new mental disorder? (2013) (4)
- Error reporting in transfusion medicine: an important tool to improve patient safety (2012) (4)
- Analysis of Hemochromatosis Gene Mutations in 52 Consecutive Patients with Polycythemia Vera (2004) (4)
- Hemophilia, cancer and cardiovascular disease. (2010) (4)
- Onset of Idiopathic Thrombocythemia after Helicobacter pylori Eradication (2005) (4)
- Implementation of a patient blood management programme in obstetrics: let's do it! (2019) (4)
- Prevalence of hepatitis C virus infection among patients with lymphoproliferative disorders: A single center survey (2007) (4)
- High‐titer convalescent plasma therapy for coronavirus disease 2019 and mortality (2021) (4)
- [Hepatitis C in hemophiliacs]. (2004) (4)
- Successful immune tolerance induction with factor VIII/von Willebrand factor concentrate in an elderly patient with severe haemophilia A and a high responder inhibitor. (2010) (4)
- O blood group and the risk of major bleeding: a single-center survey (2012) (4)
- Passive immunotherapies for COVID‐19: The subtle line between standard and hyperimmune immunoglobulins is getting invisible (2022) (4)
- Thrombosis and bleeding: when opposites are not so far apart. (2005) (4)
- A comparative method for processing immunological parameters: developing an "Immunogram". (2010) (4)
- New anticoagulants in internal medicine: an update. (2010) (4)
- Safety of Convalescent Plasma Transfusion. (2021) (4)
- Detection of chronic kidney disease in hospitalized patients: is one estimating glomerular filtration rate equation better than another? (2011) (4)
- Laboratory diagnostics in thrombosis and hemostasis: the past, the present, and the future. (2008) (4)
- The More Recent History of Hemophilia Treatment. (2022) (4)
- Possible association between reactive oxygen metabolites and karyotypic abnormalities in myelodysplastic syndromes (2003) (4)
- Proteomic analysis of venous thromboembolism: an update (2013) (4)
- Advances in managing rare acquired bleeding disorders (2020) (3)
- Is SARS‐CoV‐2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody‐based therapeutics? (2021) (3)
- Assessing options for treating haemophilia with inhibitors (2015) (3)
- Thrombocytopenia induced by a taurine-containing energy drink: an adverse reaction to herbal medicine (2014) (3)
- Onset of severe refractory thrombocytopenia following surgery in a patient with type 2B von Willebrand disease—A case report (2006) (3)
- The antiphospholipid syndrome: an update. (2006) (3)
- Neutralizing antibody levels against SARS‐CoV‐2 variants of concern Delta and Omicron in vaccine breakthrough‐infected blood donors (2022) (3)
- Troubleshooting anaemia in the elderly. (2011) (3)
- [Haemostatic abnormalities and thyroid disorders: the prospective observational MITH study]. (2014) (3)
- Alanine aminotransferase as an independent predictor of incident nonalcoholic fatty liver disease. (2007) (3)
- Are intravenous immunoglobulins really inappropriate in acquired von Willebrand syndrome? (2012) (3)
- Fish Intake and Venous Thromboembolism (2016) (3)
- Letter to the Editor regarding “Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing” (2011) (3)
- Efficacy of desmopressin in preventing hemorrhagic complications in a patient with Marfan syndrome undergoing cardiac surgery. (2006) (3)
- Convalescent plasma for COVID-19. TSUNAMI is not the final word (2022) (3)
- Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years. (2019) (3)
- Evaluation of cardiovascular risk in blood donors: results of the CARDIORISK study in the Parma Transfusion Service. (2010) (3)
- The expanding role of prophylaxis with recombinant activated factor VII. (2013) (3)
- Rodger L. Bick, M.D., Ph.D., FACP (1943-2008) (2009) (3)
- [Post-partum hemorrhage: new therapeutic options]. (2007) (3)
- [Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy]. (2013) (3)
- Self-perceived health status in blood donors. (2011) (3)
- Outpatient regimens to reduce COVID-19 hospitalizations: a systematic review and meta-analysis of randomized controlled trials (2022) (3)
- The use of banked skin in the Burns Centre of Verona. (2011) (3)
- ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers (2021) (3)
- Letter by Lippi and Franchini Regarding Article, "ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors". (2016) (3)
- Measuring accuracy of the neutralizing activity of COVID-19 convalescent plasma (2021) (3)
- Fibrinogen concentrate as haemostatic therapy in acquired bleeding disorders: not only a question of dosing strategies and thresholds. (2015) (3)
- Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall (2022) (3)
- ABO blood group and fertility: a single-centre study. (2015) (2)
- Hormones, endocrine disorders, and hemostasis. (2011) (2)
- Vegetables intake and venous thromboembolism: a systematic review (2016) (2)
- Hepcidin: the main regulator of iron homeostasis (2011) (2)
- Advancements in laboratory diagnostics: an invaluable tool for assessing quality of blood transfusions. (2014) (2)
- Uric acid concentration in patient with acute coronary syndrome (2008) (2)
- Erratum: Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy (Blood Transfusion (2014) 12 (575-98)) (2015) (2)
- A nationwide survey of clinical use of blood in Italy. (2021) (2)
- Inherited platelet disorders (Review). (2008) (2)
- The association between neonatal ABO blood group and intraventricular hemorrhage in extremely low birth weight infants: a reply to a comment (2013) (2)
- Modified Hemagglutination Tests for COVID-19 Serology in Resource-Poor Settings: Ready for Prime-Time? (2022) (2)
- The erythrocyte mean corpuscular volume is associated with serum levels of thyroid stimulating hormone in women (2008) (2)
- Screening for hemochromatosis in a population with abnormal iron status. (2003) (2)
- Safety of recombinant activated factor VII in randomized clinical trials. (2011) (2)
- [Menorrhagia and inherited disorders of coagulation]. (2002) (2)
- ABO blood group and risk of peripheral arterial thrombosis in patients with atrial fibrillation: a single center survey (2014) (2)
- The growing impact of publications in haemostasis and thrombosis journals (2007) (2)
- Effectiveness of low-dose oral calcium carbonate for the prevention of citrate-related toxicity in peripheral blood stem cell collection. (2012) (2)
- Response to “Rates of Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A Treated with Plasma-Derived or Recombinant Factor VIII: No Proof of Difference or Proof of No Difference?” (2014) (2)
- Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia. (2004) (2)
- The antiphospholipid syndrome (2005) (2)
- Anticoagulation therapy in Italy (2019) (2)
- The even closer link between the thyroid and haemostasis (2012) (2)
- Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma (2021) (2)
- Are thrombotic complications in patients with von Willebrand's disease expression of a multifactorial disease? (2005) (2)
- [Thyroid and hemostasis]. (2006) (2)
- Has homocysteine shrunk? (2007) (2)
- Fibrinogen concentrate in surgery. (2017) (2)
- Haemorrhage and amyloidosis (2013) (2)
- Relationship between 24-h air pollution, emergency department admission and diagnosis of acute coronary syndrome (2010) (2)
- Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers: a reply to a rebuttal (2012) (2)
- A forecasting model to estimate the drop in blood supplies during the SARS‐CoV‐2 pandemic in Italy (2021) (2)
- Rivaroxaban for thromboprophylaxis. (2008) (2)
- Bleeding Disorders in Primary Fibrinolysis (2021) (2)
- [The new frontiers of blood doping]. (2002) (2)
- Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies (2021) (2)
- WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients? (2023) (2)
- What a Transfusion Physician Should Know about Monkeypox Virus: Barriers to and Risks for Transmission, and Possible Mitigation Strategies (2022) (2)
- Transfusional management of a patient with anti-PP1Pk alloantibody undergoing liver transplantation. (2006) (2)
- Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. (2011) (2)
- Enabling normal psychophysical development in children with hemophilia: the choice for prophylaxis (2010) (1)
- Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues. (2021) (1)
- Surface arthroplasty increases blood loss and transfusion requirement in comparison with conventional total hip replacement. (2013) (1)
- Management of mild hemophilia A (2018) (1)
- More on air pollution and venous thromboembolism. (2017) (1)
- Chronic influence of demanding physical exercise on venous blood-gas status. (2007) (1)
- NOACs Safety and Efficacy in Different Genders Dentali (2015) (1)
- Arterial Thrombosis in Cancer Patients: An Update (2021) (1)
- Salbutamol in athletes. (2008) (1)
- Acquired Factor VII Deficiency Associated with Bronchogenic Carcinoma: A Case Report (2021) (1)
- Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma (2021) (1)
- Lower anti‐spike levels in B‐cell‐depleted patients after convalescent plasma transfusion suggest the need for repeated doses (2022) (1)
- Long-Term Pulmonary Damage From SARS-CoV-2 in an Infant With Brief Unexplained Resolved Events: A Case Report (2021) (1)
- Urological complications and copper replacement therapy in childhood Menkes syndrome (2006) (1)
- Monoclonal gammopathy of undetermined significance and Helicobacter pylori infection (2006) (1)
- Alloantibodies and Congenital Bleeding Disorders: New Insights in the Pathogenesis and Management (2018) (1)
- Role of New Potential Biomarkers in the Risk of Thromboembolism in Atrial Fibrillation (2022) (1)
- Convalescent plasma in oncohematological patients (2022) (1)
- Recombinant factorVIIa An update on its clinical use (2005) (1)
- Occult hepatitis B in blood donors: a description of two cases. (2010) (1)
- Response: Anticoagulation in splanchnic vein thrombosis (2009) (1)
- Preliminary evidence of the role of circulating testosterone levels in a cohort of women with SARS-CoV-2 infection (2021) (1)
- Response to "Parathyroid Adenoma in a Young Girl with Type 3 von Willebrand Disease". (2022) (1)
- The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing. (2017) (1)
- Lack of cross-reactivity between anti-A IgG isoagglutinins and anti-SARS-CoV-2 IgG antibodies (2021) (1)
- Inside out the thrombus: Defining the role of von Willebrand factor. (2016) (1)
- Hemostatic therapy as a management strategy for acquired hemophilia: what does the future hold? (2021) (1)
- Are haemophiliacs protected against cancer development? Prospective controlled studies are needed (2009) (1)
- Dabigratan-related acute agranulocytosis. (2019) (1)
- [Heparin-induced thrombocytopenia]. (2005) (1)
- The management of a blood donor bitten by a snake. (2017) (1)
- Relationship between von Willebrand factor, cholesterol and triglycerides in non-diabetic subjects. (2008) (1)
- Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines (2022) (1)
- Arterial thrombus formation in cardiovascular (2011) (1)
- Higher blood loss and transfusion requirement in surface arthroplasty versus conventional total hip replacement. (2019) (1)
- Efficacy of Haemate-P as prophylaxis of recurrent bleeding in a patient with type 2B von Willebrand's disease. (2005) (1)
- Lack of a prompt normalization of immunological parameters is associated with long-term care and poor prognosis in COVID-19 affected patients receiving convalescent plasma: a single center experience (2022) (1)
- Old and New Challenges in Hemophilia Management (2013) (1)
- Thrombotic and Hemorrhagic Syndromes Associated with Autoimmunity and Infection (2012) (1)
- Drug-Induced Antifactor VIII Antibodies (2007) (1)
- Outpatient Treatment of Confirmed COVID-19 (2023) (1)
- Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patients (2023) (1)
- Platelet inhibition with cangrelor. (2010) (1)
- Response to “Innovation in Hemophilia Therapies—‘And Miles to Go, before [We] Sleep’” (2016) (1)
- Definition of an organisational model for the prevention and reduction of health and social impacts of inherited bleeding disorders. (2014) (1)
- Regarding International Forum on Hospital Transfusion Services’ Response to COVID‐19 (2020) (1)
- Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for the treatment of aggressive non-Hodgkin's lymphoma in elderly patients. (2002) (1)
- New antiplatelet agents in acute coronary syndromes (ACS): an update. (2010) (1)
- Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini-Delphi Consensus (2022) (1)
- The Natural History of Hepatitis C Virus Infection in Hemophiliacs (2001) (1)
- Relationship between activated partial thromboplastin time, heparin and potassium levels. (2009) (1)
- "Efficacy and Safety of Fibrinogen Concentrate in Surgical Patients: A Meta-analysis of Randomized Controlled Trials". (2017) (1)
- [Clinical use of erythropoietin]. (2004) (0)
- Nonresponse to Interferon Monotherapy in HCV-Related Chronic Hepatitis: Results of Retreatment and Prognostic Factors (2003) (0)
- [Hereditary hemocromatosis]. (2004) (0)
- EFFICACY OF RECOMBINANT HUMAN ERYTHROPOIETIN IN FACILITATING AUTOLOGOUS BLOOD DONATION IN PAEDIATRIC PATIENTS UNDERGOING CORRECTIVE SPINAL SURGERY (2005) (0)
- Cytomegalovirus infection in patients undergoing autologous peripheral blood stem cell transplantation. (2002) (0)
- Current factor IX replacement options for hemophilia B and the challenges ahead (2023) (0)
- SARS‐CoV‐2 and the safety of blood donations: Time for a brave revision? (2022) (0)
- A severe adverse event in an elderly patient undergoing preoperative autologous blood donation. (2002) (0)
- Primary prophylaxis and early secondary prophylaxis in children (2017) (0)
- The use of recombinant factor VIIa in liver diseases. [Review] (2008) (0)
- On the persistence of the primitive chronic myeloid leukaemia cell in patients in complete molecular response. (2012) (0)
- ABO Groups and Relative Risks of Thrombosis and Bleeding Franchini , Lippi (2016) (0)
- The above letter was sent to Franchini et al.: Dr Franchini and colleagues offered the following reply (2005) (0)
- [Apheresis in ABO-incompatible kidney transplant]. (2012) (0)
- Comment to: Recombinant erythropoietin found in seized blood bags from sportsmen. Haematologica 2008;93:313–4 (2008) (0)
- Cases of acquired hemophilia A following COVID‐19 vaccines: Cogent safety signal or possible reporting/detection bias? Preliminary evidence from Tuscany, Italy (2023) (0)
- SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply (2023) (0)
- Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients—An Open-Label Phase II Clinical Trial (2022) (0)
- Emergency management of patients being treated with oral anticoagulants (2013) (0)
- COVID19 immune plasma donation after vaccination: pros and cons. (2021) (0)
- C0442: Poor Predictive Value of Contemporary Bleeding Risk Scores During Long-Term Treatment of Venous Thromboembolism: A Multicenter Retrospective Cohort Study (2014) (0)
- Hematology ADVANCES IN HEMATOLOGY (2010) (0)
- Secondary Prophylaxis in a Cohort of Adolescent and Adult Italian Hemophiliacs. (2007) (0)
- [Hemophilic arthropathy]. (2004) (0)
- Episodes of psychomotor agitation associated with trans-catheter aortic valve implantation in ICU: an observational study (2013) (0)
- Percutaneous Wallstent Implantation to Rescue Failed Ureteropyelostomy for Massive Ureteral Necrosis after Renal Transplantation (2006) (0)
- Factor VIII Deficiency or Hemophilia A: Clinical Bleeding and Management (2014) (0)
- Contents Vol. 117, 2007 (2007) (0)
- [Acquired hemophilia: update on diagnosis and treatment]. (2011) (0)
- Home and Out-of-Hospital Therapy with COVID-19 Convalescent Plasma in Europe (2022) (0)
- Next-generation treatment of acquired hemophilia A (2015) (0)
- La sindrome acquisita di von Willebrand (2006) (0)
- On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy (2022) (0)
- Regression of type 2 diabetes with imatinib (2005) (0)
- Octocog alfa, Plasma/Albumin-Free Method (2005) (0)
- Convalescent plasma special series (2021) (0)
- Pharmacotherapy of von Willebrand disease (2013) (0)
- Bioequivalence of recombinant factor VIII products: a position paper from the Italian Association of Hemophilia Centers. (2023) (0)
- Preface Controversies in Inherited Bleeding Disorders (2016) (0)
- The efficacy of phlebotomy in a patient with prior pure red cell aplasia and iron overload secondary to transfusions. (2007) (0)
- Antibodies and SARS-CoV-2: New Data on Diagnostics and Therapeutics (2022) (0)
- Colorectal cancer (CRC): program for early diagnosis in the disctrict Alba-Bra (ASl18), Piedmont - Italy (2001) (0)
- COVID-19 and pregnancy: a narrative review on the use of convalescent plasma (2021) (0)
- Current management of hemophilia B: recommendations, (2014) (0)
- Fibrinogen and Clotting Factor Replacement (2016) (0)
- Convalescent plasma regulation: A message in a bottle to the societies and regulatory authorities outside the US (2023) (0)
- Superwarfarin poisoning: a challenging diagnosis (2021) (0)
- Editorial: 'Haemophilia: new challenges and winning directions'. (2010) (0)
- Editorial (2010) (0)
- Search Methods We reviewed the medical literature for published studies on alloantibodies in patients with inherited bleeding disorders other than hemophilia (2017) (0)
- Iron overload in acute myeloid leukemia patients is not related to hemochromatosis gene mutations (2003) (0)
- [Kidney transplantation from an ABO-incompatible living donor]. (2011) (0)
- that has been in use for several years in our institution for patients with PVT. (2017) (0)
- No correlation between lipoprotein(a) and biochemical markers of renal function in the general population. (2008) (0)
- [Autoimmune thrombocytopenia: diagnosis and treatment]. (2005) (0)
- Anticoagulation in splanchnic vein thrombosis (2009) (0)
- Initial ferritin level, g/L† TIL before chelation, mg/kg‡ TIL during chelation, mg/kg‡ UIE after DFO bolus, g/48 h UIE after DFO infusion, g/48 h Follow-up time, mo Last ferritin (2017) (0)
- Emofiliaacquisita:caratteristichediagnostico-terapeutiche (2011) (0)
- Migraine, valproic acid, and lipoprotein(a). (2009) (0)
- Learn more to do better... even for participants in haemophilia clinical trials. (2015) (0)
- Pediatric Sleep-Disordered Breathing and Long-Term Complications: Clinical and Health Implications (2022) (0)
- Could the C677T mutation in the MTHFR gene be another genetic cause of arrhythmogenic right ventricular dysplasia? (2006) (0)
- Renal vein and artery thrombosis in newborn and children (2010) (0)
- Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors (2021) (0)
- Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues. (2021) (0)
- Subject Index Vol. 117, 2007 (2007) (0)
- Continuity of Care in Haemophilia: Science, Not Emotion (2017) (0)
- "The times they are a-changin", ... or maybe not? (2019) (0)
- ABO blood group and venous thromboembolism a ) Single studies (2017) (0)
- How we manage cardiovascular disease in patients with hemophilia. (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Massimo Franchini?
Massimo Franchini is affiliated with the following schools:
